Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
42.27 USD | -2.51% | -5.46% | -17.62% |
May. 21 | Bristol Myers: national schizophrenia campaign | CF |
May. 21 | Bristol-Myers Squibb Says US FDA Reassigns Action Date Subcutaneous Nivolumab | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.62% | 85.69B | |
+37.78% | 723B | |
+31.27% | 598B | |
-3.51% | 364B | |
+19.94% | 331B | |
+5.14% | 288B | |
+16.57% | 244B | |
-4.50% | 208B | |
+9.93% | 210B | |
+9.32% | 169B |
- Stock Market
- Equities
- BMY Stock
- News Bristol-Myers Squibb Company
- Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration